Plan: OPEN | Option: Growth | Sailesh Raj Bhan

16 Oct 18 | 12:00 AM

155.37 0.26 (0.17%)

  • Outperforms

    17.69%

    Return (1Y)

    beaten by 12.59%

  • Less Volatile

    0.94%

    Standard Deviation (1Y)

    Lower than by -0.18%

  • Consistent

    8/12

    Months

    Has beaten

  • Value research rating

    Not Rated

Scheme Trivia

  • Reliance Pharma Fund (G) fund has topped the 5Y performance in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has been given the best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has topped the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Reliance Pharma Fund (G), has beaten its benchmark, by 12.59% (CAGR difference)

17.69%

Outperforms

This is +ve Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Reliance Pharma Fund (G),is Lower than its benchmark, by -0.18%

0.94%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 8 out of Last 12 Months, i.e 66.67% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 11 Stocks beating the benchmark 10 Stocks not beating the benchmark

View Stock Composition